Expression and localization of human endothelin-converting enzyme-1 isoforms in symptomatic atherosclerotic disease and saphenous vein

Experimental Biology and Medicine

Volumn 231, Issue 6, 2006, Pages 794-801

  Jackson, Carolyn D ^a   Barnes, Kay ^a   Homer Vanniasinkam, Shervanthi ^b   Turner, Anthony J ^a  

^a UNIVERSITY OF LEEDS   (United Kingdom)

^b LEEDS GENERAL INFIRMARY   (United Kingdom)

Author keywords

Atherosclerosis; Endothelins; Vasculature

Indexed keywords

ENDOTHELIN CONVERTING ENZYME;

ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; CLINICAL ARTICLE; CONFERENCE PAPER; ENZYME LOCALIZATION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MACROPHAGE; PROTEIN EXPRESSION; SAPHENOUS VEIN; SMOOTH MUSCLE FIBER; STAINING; VASCULAR TISSUE;

AORTA; ARTERIOSCLEROSIS; ASPARTIC ENDOPEPTIDASES; CELL DIFFERENTIATION; CELLS, CULTURED; FOAM CELLS; HUMANS; IMMUNOHISTOCHEMISTRY; ISOENZYMES; MACROPHAGES; METALLOENDOPEPTIDASES; MONOCYTES; MUSCLE, SMOOTH, VASCULAR; SAPHENOUS VEIN;

EID: 33744900332     PISSN: 15353702     EISSN: 15353699     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (27)

1. Yanagisawa M, Kurihara H, Kimura S, Tomobe Y, Kobayashi M, Mitsui Y,Yazaki Y, Goto K, Masaki T. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 332:411-415, 1988.
2. Miyauchi T, Masaki T. Pathophysiology of endothelin in the cardiovascular system. Ann Rev Physiol 61:391-415, 1999.
3. McMurray JJ, Ray SG, Abdullah I, Dargie Hj, Morton JJ. Plasma endothelin in chronic heart failure. Circulation 85:1374-1379, 1992.
4. Bacon CR, Cary NRB, Davenport AP. Endothelin peptide and receptors in human atherosclerotic coronary artery and aorta. Circ Res 79:794-801, 1996.
5. Ehrenreich H, Andreson RW, Fox CH Rieckmann P, Hoffman FS, Travis WD, Coligan JE, Kehrl JH, Fauci AS. Endothelins, peptides with potent vasoactive properties, are produced by human macrophages. J Exp Med 172:1741-1748, 1990.
6. Sessa WC, Kaw S, Hecker M, Vane JR. The biosynthesis of endothelin-1 by human polymorphonuclear leukocytes. Biochem Biophys Res Comm 174:613-615, 1991.
7. Hirata H, Takagi Y, Fukuda Y, Marumo F. Endothelin is a potent mitogen for rat vascular smooth muscle cells. Atherosclerosis 78:225-228, 1989.
8. Lerman A, Edwards BS, Hallet JW Heublein DM, Sandberg SM, Burnett JC Jr. Circulating and tissue endothelin immunoreactivity in advanced atherosclerosis. New Eng J Med 325:997-1001, 1991.
9. Zeiher AM, Goebel H, Schachinger V, Ihling C. Tissue endothelin-1 immunoreactivity in the active coronary atherosclerotic plaque. A clue to the mechanism of increased vasoreactivity of the culprit lesion in unstable angina. Circulation 91:941-947, 1995.
10. Valdenaire O, Lepailleur-Enouf D, Egidy G, Thouard A, Barret A, Vranckx R, Tougard C, Michel JB. A fourth isoform of endothelin-converting enzyme (ECE-1) is generated from an additional promoter molecular cloning and characterisation. Eur J Biochem 264:341-349, 1999.
11. Valdenaire O, Rohrbacher E, Mattei M-G. Organisation of the gene encoding the human endothelin-converting enzyme (ECE-1). J Biol Chem 270:29794-29798, 1995.
12. Davenport AP, Kuc RE. Cellular expression of isoforms of endothelin-converting enzyme-1 (ECE-1c, ECE-1b and ECE-1a) and endothelin-converting enzyme-2. J Cardiovasc Pharm 36(5 Suppl 1):S12-14, 2000.
13. Maguire JJ, Davenport AP. Increased response to big endothelin-1 in atherosclerotic human coronary artery: functional evidence for upregulation of endothelin-converting enzyme activity in disease. Brit J Pharmacol 125:238-240, 1998.
14. Ihling C, Szombathy T, Bohrmann B, Brockhaus M, Schaefer HE, Loeffler BM. Coexpression of endothelin-converting enzyme-1 and endothelin-1 in different stages of human atherosclerosis. Circulation 104:864-869, 2001.
15. Barnes K, Turner AJ. Endothelin-converting enzyme is located on alpha-actin filaments in smooth muscle cells. Cardiovasc Res 42:814-822, 1999.
16. Minamino T, Kurihara H, Takahashi M, Shimada K, Maemura K, Oda H, Ishikawa T, Uchiyama T, Tanzawa K, Yazaki Y. Endothelin-converting enzyme expression in the rat vascular injury model and human coronary atherosclerosis. Circulation 95:221-230, 1997.
17. Wang X, Douglas SA, Louden C, Vickery-Clark LM, Feuerstein GZ, Ohlstein EH. Expression of endothelin-1, endothelin-3, endothelin-converting enzyme-1, and endothelin-A and endothelin-B receptor mRNA after angioplasty-induced neointimal formation in the rat. Circ Res 78:322-328, 1996.
18. Douglas SA, Louden C, Vickery-Clark LM, Storer BL, Hart T, Feuerstein GZ, Elliott JD, Ohlstein EH. A role for endogenous endothelin-1 in neointimal formation after rat carotid artery balloon angioplasty. Protective effects of the novel nonpeptide endothelin receptor antagonist SB 209670. Circ Res 75:190-197, 1994.
19. Brown CD, Barnes K, Turner AJ. Anti-peptide antibodies specific to rat endothelin-converting enzyme-1 isoforms reveal isoform localisation and expression. FEBS Lett 424:183-187, 1998.
20. Barnes K, Doherty S, Turner AJ. Endopeptidase-24-11 is the integral membrane peptidase initiating degradation of somatostatin in the hippocampus. J Neurochem 64:1826-1832, 1995.
21. He Y, Kwan WCP, Steinbrecher UP. Effects of oxidized low density lipoprotein on endothelin secretion by cultured endothelial cells and macrophages. Atherosclerosis 119:107-118, 1996.
22. Barnes K, Shimada K, Takahashi K, Tanzawa K, Turner AJ. Metallopeptidase inhibitors induce an up-regulation of endothelin-converting enzyme levels and its redistribution from the plasma membrane to an intracellular compartment. J Cell Sci 109:919-928, 1996.
23. Edgell C-JS, McDonald CC, Graham JB. Permanent cell line expressing human factor VIII-related antigen established by hybridization. Proc Natl Acad Sci U S A 80:3734-3737, 1983.
24. De Vries CJ, van Achterberg AE, Horrevoets AJ, ten Cate JW, Pannekoek H. Differential display identification of 40 genes with altered expression in activated human smooth muscle cells. Local expression in atherosclerotic lesions of smags, smooth muscle activation-specific genes. J Biol Chem 275:23939-23947, 2000.
25. Mikita T, Porter G, Lawn RM, Shiffman D. Oxidised low density lipoprotein exposure alters the transcriptional response of macrophages to inflammatory stimulus. J Biol Chem 276:45729-45739, 2001.
26. Bohm F, Johannsson BL, Hedin U, Alving K, Pernow J. Enhanced vasoconstrictor effect of big endothelin-1 in patients with atherosclerosis: relation to conversion to endothelin-1. Atherosclerosis 160:215-222, 2002.
27. Orzechowski HD, Richter CM, Funke-Kaiser H, Kroger B, Schmidt M. Evidence of alternative promoters directing isoform-specific expression of human endothelin-converting enzyme-1 mRNA in cultured endothelial cells. J Mol Med 75:512-521, 1997.